Eli Lilly and CompanyLLY
▲ ポジティブ技術関連度
Eli Lilly leads investor-assigned AI scores at +78, suggesting positive perception of its AI efforts despite overall skepticism.
銘柄への影響 5
Biotech & Genomic Medicine
Eli Lilly and Company
Moderna IncMRNA
▲ ポジティブ技術関連度
Moderna ranks third in AI scores at +64, indicating relatively favorable investor view on its AI integration.
Illumina IncILMN
▼ ネガティブ技術関連度
Survey shows institutional investors skeptical of AI's financial contribution in healthcare, which may dampen sentiment for Illumina's AI-related initiatives.
IQVIA Holdings IncIQV
▼ ネガティブ技術関連度
Survey indicates AI narrative overblown in healthcare, potentially reducing investor enthusiasm for IQVIA's AI-driven offerings.
Aging Population
UnitedHealth Group IncorporatedUNH
▲ ポジティブ技術関連度
UnitedHealth ranks second in AI scores at +72, reflecting strong investor confidence in its AI applications.